Skip to main content

Peer Review reports

From: A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial

Original Submission
23 Jan 2012 Submitted Original manuscript
2 Feb 2012 Author responded Author comments - Anne Katrin Berger
Resubmission - Version 2
2 Feb 2012 Submitted Manuscript version 2
3 Mar 2012 Reviewed Reviewer Report - Dirk Vordermark
Resubmission - Version 3
Submitted Manuscript version 3
22 Mar 2012 Editorially accepted
22 Mar 2012 Article published 10.1186/1471-2407-12-108

You can find further information about peer review here.

Back to article page